No Detail Found!

Neutrophils count and associated infections with clozapine treatment in patients diagnosed with Schizophrenia

Author(s)
Alaa Mohammad Noor Elahi Department of Microbiology and Medical Parasitology, Faculty of Medicine, King Abdulaziz University, Jeddah, Saudi Arabia
Mohammed Saad Almuhayawi Department of Microbiology and Medical Parasitology, Faculty of Medicine, King Abdulaziz University, Jeddah, Saudi Arabia
Rajaa Mohammed Al-Raddadi Department of Community Medicine, Faculty of Medicine King Abdul-Aziz University, Jeddah, Saudi Arabia
Abstract
 A second-generation antipsychotic drug called clozapine is used to treat resistant schizophrenia. However, therapy with clozapine is often complicated by side effects. Clozapine-associated neutropenia (CAN) is most prevalent during the initial month of treatment. This study aimed to detect the association between clozapine treatment, neutropenia and associated infections among patients with schizophrenia admitted to the Eradah and Mental Health Complex - Jeddah, Saudi Arabia. A retrospective cohort study was carried out using medical records. Neutrophil counts calculated, clozapine dose, in addition to infections, social and demographic data on fifty-one patients diagnosed with schizophrenia taking clozapine from 1st July 2018 to 30th June 2021. This paper adhered to the STROBE guidelines. Most cases who developed neutropenia are of a mild type (11%). There is no significant association between the clozapine dose and the occurrence of neutropenia in patients with schizophrenia. However, Clozapine was statistically significantly associated with an increased risk of respiratory, skin, and soft tissue infections. Moreover, age was statistically significantly associated with neutropenia occurrence. However, no statistically significant association was found between neutropenia occurrence and the other sociodemographic or clinical characteristics of the participants. Enforcing the importance of following the treatment protocol of clozapine among patients through periodic lab investigations as preventive precautions is recommended.
Publication Details
Page(s) 44-50
DOI DOI not available
Published Journal: Bioscience Research, Volume: 20, Issue: 1, Year: 2023

Request the full text from PASTIC

Keywords
neutropenia, Schizophrenia, Psychiatric, Clozapine-associated neutropenia (CAN), Clozapine
0

Citations

0

Downloads

56

Views